Virtu Financial LLC Phio Pharmaceuticals Corp. Transaction History

Virtu Financial LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$0.62 - $66.43 $2,537 - $271,897	4,093 Added 26.63%	19,464 $11,000
Q2 2022 Aug 09, 2022	SELL	$0.64 - $2.35 $17,482 - $64,192	-27,316 Reduced 63.99%	15,371 $11,000
Q1 2022 May 17, 2022	SELL	$0.73 - $1.1 $5,077 - $7,651	-6,956 Reduced 14.01%	42,687 $38,000
Q4 2021 Feb 17, 2022	BUY	$0.99 - $1.99 $4,143 - $8,328	4,185 Added 9.21%	49,643 $50,000
Q3 2021 Nov 12, 2021	BUY	$1.62 - $2.28 $29,723 - $41,833	18,348 Added 67.68%	45,458 $92,000
Q2 2021 Sep 17, 2021	BUY	$1.87 - $2.8 $21,669 - $32,446	11,588 Added 74.66%	27,110 $61,000
Q1 2021 May 19, 2021	BUY	$2.48 - $4.05 $38,494 - $62,864	15,522 New	15,522 $42,000
Q4 2020 Feb 24, 2021	SELL	$2.01 - $3.32 $72,217 - $119,284	-35,929 Closed	0 $0
Q3 2020 Dec 11, 2020	BUY	$1.95 - $2.94 $70,061 - $105,631	35,929 New	35,929 $77,000

Ticker PHIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,658,700
Market Cap $25M
Description
Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States. It offers INTASYL therapeutic platform focuses on targeting tumor and immune cells by regulating genes of the immune system. The company develops PH-762 that activates immune cells to recognize and kill cancer cells by reducing the expression of the checkpoint...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.